| Obesity |
1 |
1 |
| Lung |
0 |
0.99 |
| Asthma |
0 |
0.49 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.44 |
| Sleep |
0 |
0.29 |
| Sleep Disorders |
0 |
0.26 |
| Airway |
0 |
0.24 |
| Pulmonary Arterial Hypertension |
0 |
0.24 |
| Sleep Apnea |
0 |
0.23 |
| Exercise |
0 |
0.22 |
| Insulin Resistance |
0 |
0.22 |
| Obstructive Sleep Apnea |
0 |
0.22 |
| Tissue |
0 |
0.22 |
| Vermont |
0 |
0.22 |
| Metabolism |
0 |
0.2 |
| Muscle |
0 |
0.12 |
| Oxidative Stress |
0 |
0.1 |
| Tumor Necrosis Factor-Alpha |
0 |
0.08 |
| Body Mass Index |
0 |
0.98 |
| Cytokines |
0 |
0.07 |
| Diet |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Stress |
0 |
0.07 |
| Weight Loss |
0 |
0.07 |
| Weight Management |
0 |
0.07 |
| Blood-Brain Barrier |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Academia |
0 |
0.05 |
| Biologic Therapy |
0 |
0.05 |
| Brain |
0 |
0.05 |
| Central Nervous System |
0 |
0.05 |
| Child |
0 |
0.05 |
| Dyspnea |
0 |
0.05 |
| Hypercapnia |
0 |
0.05 |
| Hypertension |
0 |
0.05 |
| Interleukin |
0 |
0.05 |
| Pharynx |
0 |
0.05 |
| Pollutant |
0 |
0.05 |
| Microbiome |
0 |
0.04 |
| Thoracic Cavity |
0 |
0.04 |
| Toxicology |
0 |
0.04 |
| Type 2 Diabetes Mellitus |
0 |
0.04 |
| Chronic Bronchitis |
0 |
0.03 |
| COVID-19 |
0 |
0.03 |
| Obesity Hypoventilation Syndrome |
0 |
0.03 |
| Abdomen |
0 |
0.02 |
| Adherence |
0 |
0.02 |
| Antioxidant |
0 |
0.02 |
| Blood |
0 |
0.02 |
| Bronchitis |
0 |
0.02 |
| Clinical Research |
0 |
0.02 |
| Diabetes Mellitus |
0 |
0.02 |
| Emphysema |
0 |
0.02 |
| Eosinophils |
0 |
0.02 |
| Epithelium |
0 |
0.02 |
| Fatigue |
0 |
0.02 |
| Healthcare and Medical Technology |
0 |
0.02 |
| Heart |
0 |
0.02 |
| Hypoventilation Syndrome |
0 |
0.02 |
| Hypoxia |
0 |
0.02 |
| Match |
0 |
0.02 |
| Mediastinum |
0 |
0.02 |
| Medical Life |
0 |
0.02 |
| Moderate COPD |
0 |
0.02 |
| Nitric Oxide |
0 |
0.02 |
| Pathogenesis |
0 |
0.02 |
| Receptors |
0 |
0.02 |
| Severe COPD |
0 |
0.02 |
| Thorax |
0 |
0.02 |
| Tolerance |
0 |
0.02 |
| Tumor |
0 |
0.02 |
| Viral Infection |
0 |
0.02 |
| Weight Gain |
0 |
0.02 |